Good Clinical Practices (GCP) play a crucial role in finding new diagnostic methods for the modern treatment of diseases. It sets out the standards that need to be followed. Following the guidelines and the principles of the Declaration of Helsinki protects the participant’s rights in medical research involving human subjects.
As per the international standards, India has its own GCP guidelines. An Expert Committee set up by the Central Drugs Standard Control Organisation (CDSCO) in consultation with clinical experts has formulated the GCP guideline for generating clinical drug data. The Drug Technical Advisory Board (DTAB) has approved these GCP guidelines. Good Clinical Practices are fundamental to clinical research’s ethical and scientific integrity. They ultimately lead to advancements in medical knowledge and patient care.
A Look at the Regulatory Body, CDSCO
CDSCO stands for Central Drugs Standard Control Organization. Established in 1961, it operates under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India. It is India’s main regulatory body for drugs and cosmetics. The headquarters is in New Delhi, and six zonal offices, four sub-zonal offices, thirteen Port offices, and seven laboratories are spread across the country.
CDSCO is important in ensuring public well-being by implementing the New Drugs and Clinical Trial Rules, 2019 and carrying out key functions like drug approval, regulating clinical trials, quality control, policy formulation, etc. CDSCO promotes good clinical practices and ensures the reliability of medical products and services.
Navigate the regulatory landscape by ensuring compliance and success with seamless CDSCO registration for reliable drug and clinical trial standards.
What are Good Clinical Practices?
Good Clinical Practices is an international effort that guides the clinical trials to be conducted ethically and scientifically. The guidelines for GCP are defined by the International Council for Harmonisation (ICH) under the document ICH E6 (R2), which covers everything from the trial design to the final results reported.
Good clinical practices make the research safe and trustworthy. GCP plays an essential role in maintaining the rights of the consent of people in a trial process and their health.
Talk To Expert
CDSCO Releases Draft Guidelines on Good Clinical Practices
(4.8)
Know about the 13 Rules of ICH GCP
ICH GCP is a globally recognized standard that sets forth principles and guidelines for the conduct of clinical trials.
- Ethics
Clinical trials should uphold the ethics of the Declaration of Helsinki and be considered consistent with GCP.
- Risk vs. Benefit
Any foreseen risks and benefits should be considered, and the trial should only begin if the benefits surpass the risk involved.
- Rights and Safety
The rights and safety of the trial participants should prevail over the interests of science and society.
- Information on the Medicinal Product
Adequate information about the products used for the research must ensure enough evidence to start the trial.
- Quality Trials
For best results, quality must be top-notch. The trials should be scientifically sound.
- Compliance with the Study Protocol
Researchers must follow the protocols submitted to the committee before starting the trial. This is important for data integrity, participant safety, and accountability.
- Medical Decisions
Relevant licensed professionals, such as doctors, dentists, nurses, etc., should always provide medical care for trial participants. Addressing the healthcare needs of participants is important.
- Staff
The staff involved in the trial should be qualified according to the task they’ll be performing.
- Consent
The participant’s free will should obtain consent before the trial.
- Clinical Trial Data
The data should be handled properly and organized so that its reliability and accuracy can be checked.
- Confidentiality
Privacy should be maintained. No information is to be shared without permission.
- Good Manufacturing Practice (GMP)
Good manufacturing practice requires manufacturers to follow strict guidelines to maintain high quality throughout production. GMP Certification is a requirement for pharma products.
- Quality Assurance
Regularly checking and monitoring various aspects of the trial, such as how data is collected, how participants are treated, and how products are handled, ensures the quality of the trial.
Read more Blogs – Things You Should Know About Medical Device Registration
Importance of Good Clinical Practices
Understanding why Good Clinical Practices matter is important, especially if you are involved with research. Key reasons why GCP is important are:
· Participant’s Safety
The GCP standards ensure that prior consent from the participant is obtained for the research and practices, along with information on risks and benefits. Regular monitoring and reporting are also mandatory.
· Data Integrity and Quality
The guidelines help ensure the accuracy of the data collected, making the outcomes of medical research solid and trustworthy.
· Regulatory Compliance
Properly adhering to the rules of good clinical practices is very important when conducting a trial or research. Trials should be conducted legitimately to avoid the legal consequences.
· Medical Advancements
GCP has a huge hand in medical advancements that provide people with better treatment facilities. By following the guidelines, accurate and trustworthy data is collected, which is important for discoveries and advancements.
· Transparency
All the information is to be shared, which maintains honesty and ethical behaviour throughout the trial.
Read more blogs – How to Start a Pathology Lab in India?
Draft Guidelines on Good Clinical Practices by CDSCO
The Central Drugs Standard Control Organization (CDSCO) in India created new draft guidelines for Good Clinical Practices (GCP) on 13th September 2024 to ensure that biomedical studies involving human participants are conducted ethically and scientifically.
The guidelines have been extended from 121 to 151 pages by 30 pages. It is opined that the guidelines drafted will be circulated to stakeholders and also on the CDSCO website for a 30-day consultation to seek suggestions and advice before finalizing them.
Critical Aspects of the Draft Guidelines
The guidelines are drafted in accordance with the New Drugs and Clinical Trial Rules, 2019, enhancing the Indian Clinical Trials and facilitating international collaboration. The critical aspects are:
Incorporation of Technology
The guidelines emphasize innovative digital health technologies;
- Wearables and Sensors: Trackers like Wearables and Sensors help gather health data faster, monitor patients more closely, and analyze their health information more effectively.
- New Definition of Data Acquisition Tool: Covers paper and electronic tools for data collection and metadata.
New Definitions
- E-Consent: Definition for electronic informed consent processes.
- Decentralized Clinical Trials: Focus on using technology for non-site-based processes.
- Computerized Systems Validation: Outlines sponsor responsibilities regarding computerized systems used in studies.
Computerized Systems:
- A new subsection on validating electronic data processing systems is being created.
- Emphasis on a risk-proportionate approach to ensure security controls and documented procedures for data management.
Quality Assurance
Expansion of the quality assurance section to include:
- New definitions: audit, risk identification, risk control.
- A risk-based approach to quality management, integrating quality into the design of clinical studies (quality by design).
Ethics Guidance
Major revisions to the ethics section, including:
- New points on conflicts of interest.
- Guidelines on compensation for research-related harm.
- Emphasis on privacy and confidentiality protections.
Specific Study Types
Additional guidance for studies involving:
- Medical devices.
- Stem cells.
- Nanoparticles.
Inclusion of academic clinical research considerations.
Marginalized Communities and Sponsor Oversight
- Addressing issues related to marginalized communities in clinical research.
- Strengthened guidelines for sponsor oversight and monitoring of clinical trials.
Conclusion
The draft guidelines on Good Clinical Practices by the CDSCO mark an essential step forward in regulating clinical trials in India. The guidelines aim to enhance the integrity and quality of clinical research. They are expected to facilitate medical advancements, improve patient care, and bolster public confidence in clinical research, making them a crucial development in the healthcare perspective in India.
Step into the forefront of clinical research and embrace the new CDSCO guidelines by visiting our Corpbiz website to register today for a transformative journey.
Frequently Asked Questions
What are Good Clinical Practices (GCP)?
GCP is a set of international guidelines that ensure clinical trials are conducted ethically and scientifically, protecting participants’ rights and safety.
What is the purpose of the CDSCO’s draft guidelines on GCP?
The guidelines ensure that biomedical studies involving human participants are conducted ethically and scientifically.
How long are the new draft guidelines?
The guidelines have been expanded from 121 pages to 151 pages.
Why are Good Clinical Practices critical for medical advancements?
GCP ensures the collection of accurate and trustworthy data, which is essential for medical discoveries and advancements.
What are the key aspects of quality assurance in the guidelines?
The guidelines include risk-based quality management and new definitions for audit, risk identification, and risk control.
Read more Blogs – CDSCO Suspends ENTOD’s License Approval for Eye Drops
